QTI

NASD QT Imaging Holdings, Inc.
Oct 7, 2026 · 7:02 PM ET LAST TRADE Market Closed

$2.57 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.57, $0.25 below the day’s high of $2.82

YTD change
-57.10%
vs 20-day SMA
-0.41%
vs 200-day SMA
N/A

Price ranges

Previous day
$2.57 $2.77
open $2.68 close $2.58
-$0.10 (-3.63%)
Today
$2.55 $2.82
open $2.63 now $2.57
-$0.06 (-2.28%)
Past week
$2.51 $2.84
from $2.58 now $2.57
-$0.01 (-0.39%)
Past month
$2.42 $3.47
from $2.78 now $2.57
-$0.21 (-7.55%)
This year
$2.42 $7.60
from $5.99 now $2.57
-$3.42 (-57.10%)

Price & Performance

-4.39 (-62.98%) / 6M

$2.04$4.03$6.01$8.00Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 69.8% away from all-time highs of $8.50
  • QTI is down 57% since the beginning of the year
  • QTI is down 57% over the past 12 months
  • QTI is down 8% over the past 1 month
  • 2% of all QTI investors are betting against QTI

QTI reads poor: the 12-month move is -56.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.75
Earnings momentum -561.8% Quarterly EPS growth
Quarterly change -561.8%

Valuation

P/E ratio N/A
Enterprise value $43.0M
Beta 0.15

Balance sheet & scale

IncomeN/A
Revenue$26.4M
Cash$11.0M
Debt$15.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $37.6M

QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company was founded by Avi S. Katz and Raluca Dinu on January 19, 2021 and is headquartered in Novato, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.